Michael Burgess actually said...

It is vital that the Food and Drug Administration routinely incorporate the patient perspective in its decisionmaking process.

Reauthorizing the Medical Device User Fee Agreements and the user fee programs we have previously discussed would increase efficiency at FDA...

This is a good thing because it will get safe and effective products to doctors and to patients faster.

Patients have the most at stake and they deserve to be heard.